Shandong Weigao Orthopaedic Device Co., Ltd. engages in research, development, production, and sales of orthopedic medical devices. The company offers orthopedi...
Pre-market hot trades in US stocks: Planet Green fell 3.89% in pre-market; IREN rose 3.82% in pre-market
Weigao Group Flags Orthopaedic Unit Disclosure on Shanghai Exchange
CurveBeam AI Secures Device Orders, Advances China Partnership and FDA Filing in Q2 FY26
WEIGAO GROUP: WeigaoOrthopaedic's net profit attributable to the parent company in the first half of the year was 142 million yuan, a year-on-year increase of 52.43%
Bank of China International: The Medical Insurance Bureau clarifies that centralized procurement is against involution, focusing on re-evaluation opportunities in the pharmaceutical sector
Weigao Orthopaedic plans to launch a restricted stock incentive plan in 2025